Washington Trust Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Washington Trust Advisors's MDT Position: Q2 2026 in Review
Washington Trust Advisors reduced its Medtronic (MDT) stake by 22% in Q2 2026, selling an estimated $12.7K and leaving 559 shares worth $43.7K. The position accounts for ﹤0.01% of the portfolio, ranked #386.
Washington Trust Advisors first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $404K in Q4 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Washington Trust Advisors held 559 shares of Medtronic worth $43.7K as of Q2 2026.
- Washington Trust Advisors sold 158 Medtronic shares in Q2 2026, an estimated $12.7K.
- Medtronic made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #386 holding.
- Washington Trust Advisors first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
- Washington Trust Advisors's Medtronic position peaked at $404K in Q4 2021.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.